Given the role of Lewy bodies and abnormal aggregation of α-synuclein in the pathogenesis of PD, reduction of pAMPK could be an alternative way in which VEGF-B could be protective for dopaminergic neurons. The gene discussed is VEGFB; the disease is Parkinson disease.